182 related articles for article (PubMed ID: 32870133)
1. US as the Primary Imaging Modality in the Evaluation of Palpable Breast Masses in Breastfeeding Women, Including Those of Advanced Maternal Age.
Chung M; Hayward JH; Woodard GA; Knobel A; Greenwood HI; Ray KM; Joe BN; Lee AY
Radiology; 2020 Nov; 297(2):316-324. PubMed ID: 32870133
[TBL] [Abstract][Full Text] [Related]
2. Utility of Diagnostic Mammography as the Primary Imaging Modality for Palpable Lumps in Women With Almost Entirely Fatty Breasts.
Linden OE; Hayward JH; Price ER; Kelil T; Joe BN; Lee AY
AJR Am J Roentgenol; 2020 Apr; 214(4):938-944. PubMed ID: 32023120
[No Abstract] [Full Text] [Related]
3. Evaluation of abnormal mammography results and palpable breast abnormalities.
Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?
Graf O; Helbich TH; Fuchsjaeger MH; Hopf G; Morgun M; Graf C; Mallek R; Sickles EA
Radiology; 2004 Dec; 233(3):850-6. PubMed ID: 15486217
[TBL] [Abstract][Full Text] [Related]
5. Palpable breast thickening: role of mammography and US in cancer detection.
Kaiser JS; Helvie MA; Blacklaw RL; Roubidoux MA
Radiology; 2002 Jun; 223(3):839-44. PubMed ID: 12034957
[TBL] [Abstract][Full Text] [Related]
6. Utility and Outcomes of Imaging Evaluation for Palpable Lumps in the Postmastectomy Patient.
Dashevsky BZ; Hayward JH; Woodard GA; Joe BN; Lee AY
AJR Am J Roentgenol; 2019 Aug; 213(2):464-472. PubMed ID: 31039027
[No Abstract] [Full Text] [Related]
7. Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
van Zelst JCM; Mus RDM; Woldringh G; Rutten MJCM; Bult P; Vreemann S; de Jong M; Karssemeijer N; Hoogerbrugge N; Mann RM
Radiology; 2017 Nov; 285(2):376-388. PubMed ID: 28609204
[TBL] [Abstract][Full Text] [Related]
8. Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy?
Graf O; Helbich TH; Hopf G; Graf C; Sickles EA
Radiology; 2007 Jul; 244(1):87-93. PubMed ID: 17581897
[TBL] [Abstract][Full Text] [Related]
9. Role of high frequency ultrasonography in the evaluation of palpable breast masses in Chinese women: alternative to mammography?
Yang WT; Mok CO; King W; Tang A; Metreweli C
J Ultrasound Med; 1996 Sep; 15(9):637-44. PubMed ID: 8866446
[TBL] [Abstract][Full Text] [Related]
10. Clinical Value of Mammography in the Evaluation of Palpable Breast Lumps in Women 30 Years Old and Older.
Brown AL; Phillips J; Slanetz PJ; Fein-Zachary V; Venkataraman S; Dialani V; Mehta TS
AJR Am J Roentgenol; 2017 Oct; 209(4):935-942. PubMed ID: 28777649
[TBL] [Abstract][Full Text] [Related]
11. False-negative rate of combined mammography and ultrasound for women with palpable breast masses.
Chan CH; Coopey SB; Freer PE; Hughes KS
Breast Cancer Res Treat; 2015 Oct; 153(3):699-702. PubMed ID: 26341750
[TBL] [Abstract][Full Text] [Related]
12. Normal mammography and ultrasonography in the setting of palpable breast cancer.
Beyer T; Moonka R
Am J Surg; 2003 May; 185(5):416-9. PubMed ID: 12727559
[TBL] [Abstract][Full Text] [Related]
13. The role of magnetic resonance imaging in patients with palpable breast abnormalities and negative mammographic and sonographic findings.
Yalniz C; Campbell D; Le-Petross C; Shin K; Bevers TB; Hess KR; Whitman GJ
Breast J; 2020 Jul; 26(7):1289-1295. PubMed ID: 32108973
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced spectral mammography (CESM) in women presenting with palpable breast findings.
Sorin V; Faermann R; Yagil Y; Shalmon A; Gotlieb M; Halshtok-Neiman O; Ben-David MA; Sklair-Levy M
Clin Imaging; 2020 May; 61():99-105. PubMed ID: 32014818
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the results of 137 subclinical breast lesions excisions. Value of ultrasonography in the early diagnosis of breast cancer].
Jacob D; Brombart JC; Muller C; Lefèbvre C; Massa F; Depoerck A
J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):27-31. PubMed ID: 9091540
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound as a complement to mammography and breast examination to characterize breast masses.
Taylor KJ; Merritt C; Piccoli C; Schmidt R; Rouse G; Fornage B; Rubin E; Georgian-Smith D; Winsberg F; Goldberg B; Mendelson E
Ultrasound Med Biol; 2002 Jan; 28(1):19-26. PubMed ID: 11879948
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 years.
Osako T; Iwase T; Takahashi K; Iijima K; Miyagi Y; Nishimura S; Tada K; Makita M; Akiyama F; Sakamoto G; Kasumi F
Breast Cancer; 2007; 14(3):255-9. PubMed ID: 17690501
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
[TBL] [Abstract][Full Text] [Related]
19. New Palpable Breast Lump With Recent Negative Mammogram: Is Repeat Mammography Necessary?
Leung SE; Ben-Nachum I; Kornecki A
AJR Am J Roentgenol; 2016 Jul; 207(1):200-4. PubMed ID: 27081707
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
